Skip to content

Effificacy and safety of Per-oral acetic acid chromoendoscopy for sreeening precancerous lesion and early gastric cancer

Effificacy and safety of Per-oral acetic acid chromoendoscopy for sreeening precancerous lesion and early gastric cancer

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900027726
Enrollment
Unknown
Registered
2019-11-24
Start date
2019-12-01
Completion date
Unknown
Last updated
2019-11-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal diseases

Interventions

acetic acid group:Oral 2.5% 100ml acetic acid solution
control group:Oral 100ml water
Pronase Granules:No

Sponsors

Division of Gastroenterology, The First Affiliated Hospital of Nanchang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. aged 40 to 70 years; 2. Ordinary endoscopy under the suspected atrophic gastritis and / or intestinal metaplasia or chronic gastritis, gastric mucosal intestinal metaplasia, gastric polyps, residual stomach, chronic gastric ulcer or family history of tumors or high-risk patients or regular testing patients.

Exclusion criteria

Exclusion criteria: 1. patients with poor coagulation tendency and bleeding tendency; 2. Patients who have undergone gastrectomy or other changes in the normal anatomy of the gastrointestinal tract; 3. Patients with severe cardiovascular disease or other underlying diseases cannot tolerate endoscopy; 4. patients with digestive tract perforation or obstruction; 5. Patients suspected of active peptic ulcer bleeding and patients with cirrhosis and gastric varices have a risk of gastrointestinal bleeding; 6. Patients who refused to participate.

Design outcomes

Primary

MeasureTime frame
lesion detection rate;

Secondary

MeasureTime frame
Adverse reaction rate;the definition of the lesions;

Countries

China

Contacts

Public ContactZhou Xiaodong

Division of Gastroenterology, The First Affiliated Hospital of Nanchang University

yfyzxd@163.com+86 13767038587

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026